SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals - Quaterly Results

28 Jul 2025 Evaluate
The company's total revenue for the quarter ended June 2025 saw a slight change in the total revenue, having registered a total revenue of Rs. 943.70 millions.The Company's Net profit for the June 2025 quarter have declined marginally to Rs. 100.00  millions as against Rs. 121.80 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 168.80 millions from 188.80 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 943.70 920.60 2.51 943.70 920.60 2.51 3041.30 2579.80 17.89
Other Income 16.20 39.00 -58.46 16.20 39.00 -58.46 145.50 80.40 80.97
PBIDT 168.80 188.80 -10.59 168.80 188.80 -10.59 481.50 410.00 17.44
Interest 14.20 10.20 39.22 14.20 10.20 39.22 47.90 38.00 26.05
PBDT 154.60 178.60 -13.44 154.60 178.60 -13.44 433.60 372.00 16.56
Depreciation 20.60 16.10 27.95 20.60 16.10 27.95 70.50 64.00 10.16
PBT 134.00 162.50 -17.54 134.00 162.50 -17.54 363.10 308.00 17.89
TAX 34.00 40.70 -16.46 34.00 40.70 -16.46 98.60 82.10 20.10
Deferred Tax -3.00 -2.70 11.11 -3.00 -2.70 11.11 -7.20 -4.50 60.00
PAT 100.00 121.80 -17.90 100.00 121.80 -17.90 264.50 225.90 17.09
Equity 68.90 65.24 5.61 68.90 65.24 5.61 68.90 58.20 18.38
PBIDTM(%) 17.89 20.51 -12.78 17.89 20.51 -12.78 15.83 15.89 -0.38

Bharat Parenterals Share Price

1187.00 -33.40 (-2.74%)
16-Apr-2026 13:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1678.00
Dr. Reddys Lab 1224.00
Cipla 1231.55
Zydus Lifesciences 937.05
Lupin 2308.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×